Autek China Inc. (SHE:300595)
14.29
-0.07 (-0.49%)
Apr 29, 2026, 3:04 PM CST
Autek China Revenue
Autek China had revenue of 459.45M CNY in the quarter ending March 31, 2026, a decrease of -3.92%. This brings the company's revenue in the last twelve months to 1.84B, up 0.83% year-over-year. In the year 2025, Autek China had annual revenue of 1.86B with 2.62% growth.
Revenue (ttm)
1.84B
Revenue Growth
+0.83%
P/S Ratio
6.94
Revenue / Employee
491.04K
Employees
3,752
Market Cap
12.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.86B | 47.54M | 2.62% |
| Dec 31, 2024 | 1.81B | 76.44M | 4.40% |
| Dec 31, 2023 | 1.74B | 211.85M | 13.89% |
| Jan 1, 2023 | 1.53B | 230.27M | 17.78% |
| Jan 1, 2022 | 1.30B | 424.38M | 48.74% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hualan New Pharmaceutical Material | 604.86M |
| Qingdao NovelBeam Technology | 630.18M |
| Micro-Tech (Nanjing) Co.,Ltd | 3.19B |
| Tofflon Science and Technology Group | 5.22B |
| Eyebright Medical Technology (Beijing) | 1.52B |
| Sansure Biotech | 1.65B |
| Shenyang Xingqi Pharmaceutical | 2.47B |
| Winner Medical | 11.02B |